Anavex Life Sciences
AVXL
AVXL
140 hedge funds and large institutions have $113M invested in Anavex Life Sciences in 2024 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 42 increasing their positions, 42 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
22% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 27
30% less capital invested
Capital invested by funds: $161M → $113M (-$48.1M)
Holders
140
Holding in Top 10
–
Calls
$4.18M
Puts
$3.44M
Top Buyers
| 1 | +$2.47M | |
| 2 | +$2.01M | |
| 3 | +$1.89M | |
| 4 |
Renaissance Technologies
New York
|
+$1.63M |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$844K |
Top Sellers
| 1 | -$15M | |
| 2 | -$4.1M | |
| 3 | -$3.21M | |
| 4 |
Citigroup
New York
|
-$2.19M |
| 5 |
Rafferty Asset Management
New York
|
-$1.88M |